FinTrust Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$65.1K	Hold	140	–	–	0.01%	510
2024 Q2	$65.6K	Buy	140 +16	+13%	+$6.95K	0.01%	477
2024 Q1	$51.8K	Hold	124	–	–	0.01%	510
2023 Q4	$50.5K	Buy	124 +10	+9%	+$3.69K	0.01%	487
2023 Q3	$39.6K	Sell	114 -160	-58%	-$56K	0.01%	504
2023 Q2	$79.1K	Hold	274	–	–	0.02%	382
2023 Q1	$79.1K	Hold	274	–	–	0.02%	380
2022 Q4	$79.1K	Sell	274 -1,000	-78%	-$305K	0.02%	380
2022 Q3	$371K	Buy	+1,274	New	+$367K	0.1%	187
2021 Q3	–	Sell	-50	Closed	-$10K	–	1221
2021 Q2	$10K	Sell	50 -9	-15%	-$1.88K	﹤0.01%	945
2021 Q1	$13K	Hold	59	–	–	﹤0.01%	839
2020 Q4	$14K	Sell	59 -264	-82%	-$60.6K	﹤0.01%	763
2020 Q3	$88	Buy	323 +10	+3%	+$2.76K	0.02%	384
2020 Q2	$91K	Sell	313 -24	-7%	-$6.51K	0.04%	356
2020 Q1	$80K	Buy	337 +16	+5%	+$3.67K	0.04%	328
2019 Q4	$70K	Sell	321 -27	-8%	-$5.46K	0.03%	384
2019 Q3	$59K	Hold	348	–	–	0.02%	416
2019 Q2	$63K	Sell	348 -24	-6%	-$4.2K	0.03%	371
2019 Q1	$68K	Sell	372 -30	-7%	-$5.54K	0.03%	339
2018 Q4	$67K	Buy	+402	New	+$69.7K	0.03%	326